NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/22/2024
Back to search
Official data from USPTO
PHARMACEUTICAL MANUFACTURING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMACEUTICAL MANUFACTURING
ST13
US500000076423859Class
16
Filing
76423859
Registration
2814334
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
05/22/2024
Trademark type
Word
Nice classes
16
Filing date
06/24/2002
Registration date
02/10/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/22/2024
Last transaction
05/22/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
10/01/2002
First use in commerce
10/01/2002
Drawing code
1
Owner type
16
Owner location
NASHVILLE, TN
Examiner
SALEMI, DOMINICK
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ENDEAVOR BUSINESS MEDIA, LLC
Putman Media, Inc.
Putman Media, Inc.
Representatives
Kevin P. Hartley Trust Tree Legal, P.C.
Technical classification
Nice Classes
Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Publication; namelya magazine delivering unique editorial content concerning emerging technologiesequipmentautomation and control systemsinformation management and compliance systemsbusiness strategies for the development of medicines
Publications
History of USPTO decisions and trademark events.
34 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
05/22/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/22/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/21/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
02/08/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/21/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/21/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/15/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/21/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/21/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/21/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/21/2014
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
02/07/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
02/07/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
10/01/2009
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/01/2009
ES8R
TEAS SECTION 8 RECEIVED
09/15/2009
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
02/10/2004
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/21/2003
IUAA
USE AMENDMENT ACCEPTED
11/21/2003
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
11/18/2003
CFIT
CASE FILE IN TICRS
11/04/2003
IUAF
USE AMENDMENT FILED
09/22/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2003
PAPER RECEIVED
09/22/2003
CNFR
FINAL REFUSAL MAILED
06/12/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2003
PAPER RECEIVED
05/02/2003
CNRT
NON-FINAL ACTION MAILED
12/02/2002
DOCK
ASSIGNED TO EXAMINER
11/22/2002
Continuous trademark protection
Get notified about every new filing that threatens PHARMACEUTICAL MANUFACTURING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.